Anti-inflammatory agent reduces both first and recurrent events post-MI3' education - Dec. 19, 2019 - Jean-Claude Tardif, Montreal - AHA 2019, Philadelphia
This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.
Dr. Jean-Claude Tardif is the Director of the Research Centre at the Montréal Heart Institute and Professor of Medicine at the University of Montréal.
This video was recorded at the congress of the American Heart Association in Philadelphia, on November 16-18, 2019.